Home "Dare to Be Bold, Ask No East or West": The 7th Future Healthcare 100 Summit Unveils Its Structure and Offerings

"Dare to Be Bold, Ask No East or West": The 7th Future Healthcare 100 Summit Unveils Its Structure and Offerings

Mar 01, 2023 10:43 CST Updated 10:43

主k定稿.jpg


Over the past decade, the global healthcare industry has undergone significant transformation, a process accelerated by the COVID-19 pandemic since 2020. Having withstood the compounded challenges of global geopolitical shifts in 2022 and the ongoing pandemic, 2023 marked the first year for implementing the strategic directives laid out at the 20th National Congress of the Communist Party of China, as well as a critical year for advancing the 14th Five-Year Plan. Only by accumulating strength, demonstrating the resilience captured in the phrase “standing firm despite countless trials,” and embodying the spirit of “pressing forward amid greater difficulties,” can innovators in the healthcare sector reinforce their confidence through decisive action, thereby delivering a high-quality response to the era’s demands for the advancement of healthcare.


As an industrial service brand focused on the healthcare sector, VCBeat’s VB100 has kept pace with the times. Over the past six editions, the Future Healthcare 100 Conference has witnessed the remarkable development of China’s broader health industry and the rise of innovative forces across its value chain. Throughout these six years, the conference framework has been continuously upgraded, gradually evolving into an innovation-focused ecosystem that connects innovative enterprises, industrial capital, healthcare service providers, research universities, and industrial parks.


Rooted at the forefront of the industry, the Future Healthcare 100 Conference is dedicated to leading and promoting high-quality development and innovative progress in China’s medical and health sector. In 2023, we celebrated its seventh edition, spearheaded by top academic and scientific experts including academicians. The conference gathered outstanding global medical and health innovation projects and scientific research achievements, strategic announcements from listed companies, and benchmarks for industry innovation. It mapped out an era where China’s medical health research is closely linked and positively interacts with the construction of its public health system, recorded the historical strides of China’s medical health innovation, and showcased the confident, determined, and relentless spirit of China’s medical and health sector as it forges ahead regardless of origins or boundaries.


The 7th Future Healthcare Top 100 ConferencebyVB100、VCBeat,VCBeatHosted by; Strategic Cooperation with Shanghai Zhangjiang Group, scheduled forMay 5–7, 2023InShanghai Zhangjiang Science Hallheld. The conference covers five major products, including three blockbusterSummit, 20+ Sub-sectorsThematic Forum, Future Healthcare Top 100 SeriesRankings and Awards, 10+ SeriesReport、7 Major Concurrent EventsExchange Activities


Three summits precisely focused on industry development trends,Leading Enterprise Strategies, New Trends in Venture Capital


Trend Summit

Core Values

To help innovators map out future industry trends and enhance their understanding of the sector;


Core Content

1. Full-Chain Empowerment Drives Regional Economic Development and New Growth in the Zhangjiang Biopharmaceutical Cluster;

2. Global Perspective: Exploring World-Class Medical Innovation and Transformation;

3. New Healthcare Infrastructure: Accessibility, Affordability, and Sharing of Medical Services;

4. Insights into the Wave of Chinese Pharmaceutical and Medical Device Companies Expanding Overseas Amid Global Supply Chain Restructuring;

5. Frontier technological shifts driven by the data revolution, including AI-driven drug discovery, RNA therapies, organoids, and organ-on-a-chip;

6. Practical Exploration of Med-Engineering Interdisciplinarity and Translation of Research Findings.

Leader Summit

Core Values

Listen to the business wisdom of leading entrepreneurs and gain insights into the operational strategies of industry-leading enterprises;


Core Content

1. Financial Innovation Boosts the Development of the Healthcare Industry, with Strong Support from Industrial Securities Economic and Financial Research Institute;

2. Outlook on Innovation Trends and Opportunity Identification in the Future of Global Healthcare;

3. Comprehensive business insights from leaders of 10+ listed industry giants;

4. Amid the Wave of Globalization: An Analysis of Future Trends in Medical Technology Innovation and Value Investment


Top 100 Summit

Core Values

To shape industry influence for innovators and build brand recognition for enterprises;


Core Content

1. The Rise of Pharmaceutical and Medical Device CROs/CDMOs;

2. Disruptive innovations in hard-core medical technologies such as CGT, nucleic acid-based drugs, and brain science;

3. New Entry Points for the High-Quality Development of the Silver Economy;

4. Game-changer and innovator in upstream raw materials;

5. System innovation in medical services such as dentistry, ophthalmology, rehabilitation, and medical aesthetics;

6. Digital Empowerment: Building a New Ecosystem for Smart Healthcare.

Subject to the actual conference agenda.

List of Guests at Previous Summits (Main Forums)


微信图片_20230301093242.png

Selected Past Speakers (Scroll Down)

Note: The titles of the speakers refer to their positions at the time of their presentations in that year.


20+ Thematic Forums on Niche Sectors: Exploring the Most Pressing Topics and Gauging Industry Trends


The 7th Future Healthcare Top 100 Conference conducts a comprehensive review of four major sectors: medical devices, biopharmaceuticals, digital health, and healthcare services. It has curated over 20 themed sub-forums focused on hot-track areas, dedicated to discovering new technologies, new business formats, and new models in the broader health industry, while jointly promoting long-term investment strategies within the sector. Serving as a stage for benchmark innovators in high-growth fields to share insights and as a platform for investors to uncover valuable opportunities, these themed forums cover industry observations and trend forecasts, explore innovation trends and cutting-edge technologies, analyze highly innovative and representative leading companies, and outline the focus areas and investment rationales of prominent investment firms in these hot tracks. Meanwhile, these themed forums will be co-hosted with top-tier investment institutions and associations, having already secured support from includingLegend Capital, Matrix Partners China, China Renaissance, Jinding Capital, Tsinghua Unigroup Holdings Fund, Weilai Capital, Huagai Capital, Qiming Venture Partners, Boyuan Capital, Hetang Venture Capital, Proxima Ventures, Yueyin Medical Fund, 5Y Capital, CDH VGC, GTJA Investment(listed in order of confirmed collaboration time, not by ranking) including15 institutionsCooperation and support from institutions.


微信图片_20230301093237.png

Thematic Forum Area Planning; subject to the actual conference agenda.


Top 100 Future Healthcare Companies: 5 Authoritative Rankings to Identify the Core Forces of the Industry


Over the past seven years, the ranking system of the Future Healthcare 100 has been continuously enriched, gradually establishing a global innovative healthcare ecosystem ranking that serves enterprises, investment institutions, hospitals, and industrial parks. To date, it has released161 lists/awards, a cumulative total of 2,964 listed companies, and the cumulative valuation of companies listed over the past 22 years reached RMB 1,452.986 billion


“The Top 100 Future Healthcare Companies” ranking has become an authoritative and objective evaluation standard and system for China’s healthcare innovation industry. It is currently the most watched annual selection in the life and health sector by both the industry and investment communities, and the awards ceremony has become a major annual industry event. In 2023, the “Top 100 Future Healthcare Companies” list was upgraded once again, adopting five categories of authoritative evaluations to identify the core forces driving the industry, including6 Main Lists, N+ Awards in Specialized Value Sectors, 2 Categories with 20+Awards


The main list includesChina’s Top 100 Innovative Medical Devices, China’s Top 100 Innovative Digital Health Solutions, China’s Top 100 Innovative Healthcare Services, China’s Top 100 Healthcare Commerce and Supply Chain Services, China’s Top 100 Innovative Biopharmaceuticals, Top 100 Innovative Overseas HealthcareMeanwhile, the ranking’s selection ecosystem continues to expand toward listed companies, with the organizing committee continuing the addition introduced in 2022 ofListed Companies' Innovation Power RankingValue Domain AwardIn terms of sectors, we conduct a comprehensive review of over 60 sub-sectors across four major tracks: medical devices, biopharmaceuticals, digital health, and healthcare services. We identify the most representative high-value segments of the year and select the most representative and high-growth innovative enterprises within each value segment. Regarding awards, they includePengcheng Award, Weilan AwardTwo major award categories, open to institutions, industrial parks, enterprises, investors, and entrepreneurs.


10+ Industry Reports: A Feast of Cutting-Edge Industry Insights


《Analysis Report on the Growth of Top 100 Enterprises》: The first in-depth report in China to analyze the growth trajectories of the top 100 most valuable non-listed healthcare innovation companies. Each year, based on the Future Healthcare 100 list, VCBeat VB100 conducts a comprehensive analysis of data related to the companies on the main list, summarizing patterns of corporate growth and trends in industrial evolution to provide reference and insights for healthcare enterprises and entrepreneurs. The report’s innovative case study chapter is open to submissions from all companies listed in the current edition. We aim to identify the most representative innovative and high-potential enterprises in the healthcare industry, and through in-depth research into their business, product, financing, and valuation data, observe the growth trajectories of healthcare companies and the direction of transformation in the healthcare industry from a more authentic and comprehensive perspective.


Over 10 Sub-Forum Reports on Niche SectorsVCBeat’s Future Healthcare Top 100: To better analyze the drivers and current development status of popular healthcare subsectors both domestically and internationally, VCBeat will release in-depth industry reports on these subsectors. These reports will be based on a comprehensive review of prominent healthcare subsectors and aligned with the themes and forum structure of this year’s Top 100 Conference, includingGenetic Testing, Digital Pharmaceutical Marketing, Health Insurance, Organoids, Radiopharmaceuticals, Energy-Based Aesthetic Devicesetc.


4 Formats, 7 Concurrent Exchange Activities


With the comprehensive lifting of pandemic restrictions, offline events are making a high-profile comeback. In 2023, participating in exhibitions and conferences, engaging in face-to-face exchanges, and conducting on-site visits and experiences will become key options for companies to stay in sync with the market. As an annual flagship event exploring trends in the healthcare industry, the Future Healthcare Top 100 Conference will create a communication and matchmaking platform covering the entire healthcare industry chain by offering four formats and seven concurrent exchange activities, thereby efficiently linking all essential resources across industry, academia, research, and investment.


Promotion and Exchange

Global Innovation Project Pitch:Building on our commitment to connecting venture capital investors with entrepreneurs and facilitating dialogue between overseas healthcare companies and leading investment firms, we aim to enrich the global healthcare venture capital ecosystem. Through an innovative format combining “destination promotion + project roadshows + capital interaction,” we provide a public platform for outstanding global healthcare innovation projects. This roadshow will feature representatives from more than six countries/regions and invite top-tier investment institutions to participate in evaluations and interactive discussions, offering in-depth insights into project highlights and delivering high-quality expert perspectives.


Roadshow for the Commercialization of Scientific Research Achievements:To explore key directions for the commercialization of medical scientific and technological achievements and to build an interactive platform for early-stage venture capital engagement, the Scientific Research Achievement Commercialization Roadshow will bring together top-tier research institutes to delve into commercialization practices and trends; feature prominent investors from early-stage investment firms sharing their investment strategies; and showcase 6–8 high-quality innovative projects participating in roadshow interactions.


Corporate/Product Promotion Conference:The “Emerging Talent Stage” behind the main conference stage, tailored for corporate and institutional clients, fully addresses personalized needs such as brand promotion, product showcases, business matchmaking, and investment–financing interactions, delivering a novel one-to-many interactive experience.


Conference Exchange

Closed-Door Seminar:Efficient discussions and dedicated liaison with government and corporate decision-makers through face-to-face engagement. This facilitates cooperation between government and enterprises in areas such as communication, market entry, and investment. By leveraging the government’s advantageous resources, we precisely identify corporate pain points and needs, rapidly define solutions, help entrepreneurs find new operational bases, and support businesses in achieving swift establishment and growth.


Ecosystem Conference:Investment Institutions, Industry Giants, and Platform Companies Ecosystem Conference: Expanding Industrial Resources, Exploring Ecosystem Development and Collaboration Opportunities.


Exhibition Area Exchange

Exhibition of Innovative and Entrepreneurial Enterprises:Centered on “brand promotion for innovative enterprises, product showcases, and exhibition windows for investment institutions and ecosystem-enabling organizations,” the initiative aims to create a display and exchange platform that complements the knowledge sharing and intellectual discourse of the Top 100 Conference.


Matchmaking and Negotiation Area:An open interactive space for guests, investors, corporate leaders, and attendees to facilitate one-on-one interactions such as financing matchmaking, resource exchange, and face-to-face meetings with industry network members. It features a Public Negotiation Area, a Venture Capital Negotiation Area, and a Themed Negotiation Area.


Dinner Networking

Top 100 Gala:An annual gala and high-level networking platform for decision-makers and executives from companies and institutions listed on the 2022–2023 Future Healthcare Top 100. (Open exclusively to attendees at the vice president level or above; registration is subject to organizer approval.)


微信图片_20230222103159.jpg


General Admission Pass: ¥699


○ Early Bird Limited-Time Discount, Only for Sale299Yuan


VB100通用渠道码.png


Your trust will grant you the following benefits:

1. 3-day forum + all-access pass to the Top 100 Exhibition Area + 3 days of basic light meals (lunch)

2、Excludes lunch vouchers, the Top 100 Gala Dinner, the LP-GP Summit, and invitation-only meetings.

3. Forum Reports (Electronic Version)

4. On-Site Resource Coordination Group

5. Authorization of Guests' PPTs and Other Materials



Conference VIP Ticket: ¥1,999


○ Early Bird Limited-Time Discount, Only1299Yuan


VB100通用渠道码.png


Your trust will entitle you to the following benefits:

1. Includes all benefits of the [Conference General Pass]

2、3-day upgrade from set meals to buffet (lunch), LP-GP Summit ticket

3. TicketsNot includedTop 100 Gala,Invitation-Only Meeting



Top 100 Gala Dinner VIP Ticket: ¥4,999


○ Tickets are sold exclusively to corporate executives at the Vice President level and above.

○ Limited to 100 spots; registration requires approval by the organizer.


VB100通用渠道码.png


* Top 100 Gala for the 2022-2023 Future Healthcare 100 ListDecision-Making Executives in Enterprises and InstitutionsAnnual gala and high-level exchange platform.


Your trust will grant you the following benefits:

1. Includes all benefits of the [Conference VIP Ticket]

2. One Complimentary TicketTop 100 Gala Dinner Tickets

3、TicketExcluding Targeted Invitation Meetings



University Student Ticket: $0


○ Tickets are sold exclusively to currently enrolled university students.

○ Student ID card required,Submit to Organizer for Review


VB100通用渠道码.png


Your trust will grant you the following benefits:

1. 3-Day Forum + Top 100 Exhibition Area Pass + 3-Day Basic Light Meals (Lunch)

2、Excludes the Top 100 Gala, LP-GP Summit, and invitation-only meetings.

3. Reports Released by the Forum (Electronic Version)

4. On-site Resource Coordination Group

5. Guest Authorization for PPT and Other Materials


微信图片_20230301093230.png

**Special Note: Ticket prices will gradually increase as information regarding the conference theme, speakers, topics, and exhibitors is announced, until they return to the original price. Early purchase is recommended.**


微信图片_20230227141351.jpg


Learn More About the Future Healthcare Top 100 Conference and Rankings

Welcome to contact the organizing committee for inquiries.


Conference and Media Partnerships: Mr. Weng

15922837745 (same as WeChat)

微信图片_20230213170608.jpg

Conference & Exhibition Partnership:Ms. Liu

18883315091 (WeChat)

微信图片_20230227141618.jpg

Report Inclusion and Award Inquiry:Ms. Li

18428384021 (WeChat)

微信图片_20230214142927.png

List Declaration:Ms. Peng

13364027163 (WeChat)

微信图片_20230214142918.jpg

List Submission: Ms. Wu

15696132719 (WeChat)

微信图片_20230214142922.jpg

Upon additionPlease note: "Name-Company-Position-Requirement"